AlphaCentric Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-239,500
Closed -$611K 284
2023
Q1
$611K Sell
239,500
-175,500
-42% -$503K 0.42% 78
2022
Q4
$1.04M Buy
415,000
+187,500
+82% +$523K 1.03% 33
2022
Q3
$660K Buy
+227,500
New +$958K 0.68% 50

Other funds holding SLGC

AlphaCentric Advisors's SLGC Position: Q2 2023 in Review

AlphaCentric Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2023, closing a stake of 239,500 shares — an estimated $611K sold.

AlphaCentric Advisors first reported a position in SLGC in Q3 2022 and held it in 3 quarters. The position peaked at $1.04M in Q4 2022. 123 funds tracked by Wall St. Rank hold SLGC as of Q2 2023.

  • AlphaCentric Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • AlphaCentric Advisors sold 239,500 SomaLogic, Inc. Class A Common Stock shares in Q2 2023, an estimated $611K.
  • AlphaCentric Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • AlphaCentric Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $1.04M in Q4 2022.
  • 123 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2023.

Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.